Academic pharmacist Nataly Martini highlights the importance of understanding non-Hodgkin lymphoma and pharmacists’ roles in managing this condition
Friday 1 November 2024, 01:00 AM
14 minutes to Read
The number of people taking funded dulaglutide (Trulicity) has doubled in New Zealand over the past two years and the diabetes medicine is in short supply again, along with its alternative, Victoza (liraglutide). Natasha Jojoa Burling reports